These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11081540)

  • 1. Onset of coeliac disease during treatment with interferon for chronic hepatitis C.
    Cammarota G; Cuoco L; Cianci R; Pandolfi F; Gasbarrini G
    Lancet; 2000 Oct; 356(9240):1494-5. PubMed ID: 11081540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease.
    Adinolfi LE; Durante Mangoni E; Andreana A
    Am J Gastroenterol; 2001 Feb; 96(2):607-8. PubMed ID: 11232725
    [No Abstract]   [Full Text] [Related]  

  • 3. Onset of coeliac disease and interferon treatment.
    Bourlière M; Oulés V; Perrier H; Mengotti C
    Lancet; 2001 Mar; 357(9258):803-4. PubMed ID: 11253998
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic viral hepatitis, interferon, diabetes mellitus, and celiac disease.
    Narváez I; Pérez B; del Mar Alcalde M; Jiménez C; Soria A
    Am J Gastroenterol; 2003 Oct; 98(10):2336-7. PubMed ID: 14572601
    [No Abstract]   [Full Text] [Related]  

  • 5. Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection.
    Papastathopoulos K; Bouzas E; Naoum G; Vergados I; Tsiodras S
    J Infect; 2006 Feb; 52(2):e59-61. PubMed ID: 15951019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-ribavirin-associated ischemic colitis.
    Punnam SR; Pothula VR; Gourineni N; Punnam A; Ranganathan V
    J Clin Gastroenterol; 2008 Mar; 42(3):323-5. PubMed ID: 18223489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous, pulmonary and hepatic sarcoidosis associated with autoimmune complications during interferon-alpha treatment for hepatitis C virus infection.
    Akay BN; Ekmekci P; Sanli H; Celik G; Bozdayi M
    J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):442-5. PubMed ID: 16643145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C.
    Li Z; Zhang Y; An J; Feng Y; Deng H; Xiao S; Ji F
    J Clin Virol; 2014 Jul; 60(3):190-5. PubMed ID: 24830933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection.
    Behnam SE; Hindiyeh R; Fife DJ; Jeffes EW; Wu JJ
    Clin Exp Dermatol; 2010 Jun; 35(4):397-8. PubMed ID: 19663835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silent celiac disease in chronic hepatitis C: impact of interferon treatment on the disease onset and clinical outcome.
    Durante-Mangoni E; Iardino P; Resse M; Cesaro G; Sica A; Farzati B; Ruggiero G; Adinolfi LE
    J Clin Gastroenterol; 2004; 38(10):901-5. PubMed ID: 15492610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
    Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interferon-alpha and ribavirin: advances in the therapy of chronic hepatitis C].
    Zeuzem S
    Dtsch Med Wochenschr; 1999 May; 124(20):636-42. PubMed ID: 10370387
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of chronic viral hepatitis].
    Pedersen C; Pedersen CR
    Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of chronic hepatitis C].
    Bell H; Dalgard O; Bjøro K; Hellum KB; Myrvang B
    Tidsskr Nor Laegeforen; 2002 Apr; 122(9):926-8. PubMed ID: 12082838
    [No Abstract]   [Full Text] [Related]  

  • 15. Concurrent antiphospholipid syndrome and cutaneous [corrected] sarcoidosis due to interferon alfa and ribavirin treatment for hepatitis C.
    Shinohara MM; Davis C; Olerud J
    J Drugs Dermatol; 2009 Sep; 8(9):870-2. PubMed ID: 19746680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An adult case with onset of celiac disease during chronic hepatitis C antiviral treatment.
    Ioniţă-Radu F; Bucurică S; Costache R; Nuţă P; Stanciu S
    Rom J Intern Med; 2010; 48(1):105-8. PubMed ID: 21180248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celiac disease in chronic hepatitis C patients under pegylated-interferon plus ribavirin treatment. Preliminary results of a prospective single center study.
    Elefsiniotis IS; Fotos NV; Pantazis KD; Papadeli D; Mavrogiannis C
    Hepatogastroenterology; 2007; 54(75):2 p preceding table of contents. PubMed ID: 17591034
    [No Abstract]   [Full Text] [Related]  

  • 18. Late development of diabetes mellitus after interferon-alfa and ribavirin therapy for chronic hepatitis C: a case report.
    Radhakrishnan S; Upadhyay A; Mohan N; Dhar A; Walia HK; Zubaidi G
    Med Princ Pract; 2005; 14(4):281-3. PubMed ID: 15961942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C.
    Schmidt F; Janssen G; Martin G; Lorenz R; Loeschke K; Soyka M; Folwaczny C; Schaefer M
    Aliment Pharmacol Ther; 2009 Nov; 30(10):1049-59. PubMed ID: 19691667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders.
    Brillanti S; Foli M; Di Tomaso M; Gramantieri L; Masci C; Bolondi L
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):130-4. PubMed ID: 10363198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.